- Home
- SBLK vs LGND Comparison
SBLK vs LGND Comparison
Compare SBLK & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBLK | LGND |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2007 | 1997 |
Fundamental Metrics
Financial Performance| Metric | SBLK | LGND |
|---|---|---|
| Price | $29.55 | $302.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $25.50 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 1.5M | 164.8K |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | ★ 2886.36 |
| EPS | N/A | ★ 1.63 |
| Revenue | N/A | ★ $141,102,000.00 |
| Revenue This Year | $11.56 | $1.25 |
| Revenue Next Year | N/A | $19.41 |
| P/E Ratio | ★ $47.06 | $183.46 |
| Revenue Growth | N/A | ★ 29.48 |
| 52 Week Low | $16.72 | $166.10 |
| 52 Week High | $32.88 | $326.63 |
Technical Indicators
Market Signals| Indicator | SBLK | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 65.55 |
| Support Level | $29.42 | $286.99 |
| Resistance Level | $32.88 | $317.49 |
| Average True Range (ATR) | 0.82 | 8.66 |
| MACD | -0.31 | 2.57 |
| Stochastic Oscillator | 10.94 | 99.79 |
Price Performance
Historical ComparisonAbout SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.